Skip to main content
LETTER TO THE EDITOR

Low-Dose Risperidone for an Autistic Child with Comorbid ARFID and Misophonia

Psychopharmacology Bulletin 52(1): 91-94, 2022/02/25; https://doi.org/10.64719/pb.4430

Abstract

Avoidant/Restrictive Food Intake Disorder and misophonia seem to be overrepresented in autism spectrum disorder. Literature is mute on psychopharmacotherapy in these complex presentations. Here, authors report on a challenging case of low-functioning ASD child with comorbid ARFID and misophonia that responded favorably to a low-dose risperidone. This is followed by a brief discussion of purported pharmacodynamic mechanisms and relevant literature.

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Ahmed Naguy, Abdul-Mohsen Al-Humoud, Saxby Pridmore, Mohamed Y Abuzeid, Anubhuti Singh, Dalal Elsori. Low-Dose Risperidone for an Autistic Child with Comorbid ARFID and Misophonia. Psychopharmacology Bulletin. 2022/02/25; 52(1):91-94. https://doi.org/10.64719/pb.4430